Home 9 Scientific Committees 9 Committee on LOW RISK HPV

Committee on LOW RISK HPV

Chairperson:

F. G. Dikkers, The Netherlands

 

Members:

  • R. Tjon Pian Gi, The Netherlands
  • T. Ilmarinen, Finland
  • L-M Aaltonen, Finland
  • A. Dietz, Germany
  • V. Djukic, Serbia
  • H. Eckel, Austria
  • G. Friedrich, Austria
  • W. Golusinski, Poland
  • A. Hantzakos, Greece
  • G. Lawson, Belgium
  • M. Remacle, Belgium
  • W. Szyfter, Poland
  • M. Wierzbicka, Poland
  • A. Rørbæk Madsen, Denmark
  • C. Arens, Germany
  • Y. Karagama, UK
  • D. Novakovic, Australia
  • G. Sandhu, UK

PUBLICATIONS OF THIS COMMITTEE:

Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.
Tjon Pian Gi RE, Ilmarinen T, van den Heuvel ER, Aaltonen LM, Andersen J, Brunings JW, Chirila M, Dietz A, Ferran Vilà F, Friedrich G, de Gier HH, Golusinski W, Graupp M, Hantzakos A, Horcasitas R, Jackowska J, Koelmel JC, Lawson G, Lindner F, Remacle M, Sittel C, Weichbold V, Wierzbicka M, Dikkers FG
Eur Arch Otorhinolaryngol. 2013 May;270(5):1679-87

Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®).
Tjon Pian Gi RE, Dietz A, Djukic V, Eckel HE, Friedrich G, Golusinski W, Hantzakos A, Lawson G, Remacle M, Rihkanen H, Dikkers FG
Eur Arch Otorhinolaryngol. 2012 Feb;269(2):361-2